Detalhe da pesquisa
1.
B cells and tertiary lymphoid structures promote immunotherapy response.
Nature
; 577(7791): 549-555, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31942075
2.
Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicities.
Proc Natl Acad Sci U S A
; 116(44): 22246-22251, 2019 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31611368
3.
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer.
Proc Natl Acad Sci U S A
; 116(5): 1692-1697, 2019 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30635425
4.
The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
Cancer
; 125(9): 1470-1481, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30500073
5.
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 18(4): 446-453, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28223062
6.
Levels of CD8+ tumor infiltrating lymphocytes correlate with disease burden in bone marrow of therapy Naïve multiple myeloma patients.
Ann Diagn Pathol
; 40: 174-175, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30509755
7.
Activation of nuclear factor κB (NF-κB) in prostate cancer is mediated by protein kinase C epsilon (PKCepsilon).
J Biol Chem
; 287(44): 37570-82, 2012 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-22955280
8.
Antitumor activity of tumor-targeted RNA replicase-based plasmid that expresses interleukin-2 in a murine melanoma model.
Mol Pharm
; 10(6): 2404-15, 2013 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23641783
9.
Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial.
Cancer Discov
; 13(11): 2394-2411, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37707791
10.
Protective role of cathepsin L in mouse skin carcinogenesis.
Mol Carcinog
; 51(4): 352-61, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21538579
11.
A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma.
Clin Cancer Res
; 28(14): 3032-3041, 2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507017
12.
Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers.
Oncoimmunology
; 10(1): 1943253, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34290906
13.
PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth.
Am J Pathol
; 174(5): 1869-79, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19395652
14.
ARID1A mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC.
Sci Transl Med
; 12(548)2020 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32554706
15.
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma.
Nat Med
; 26(1): 39-46, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31873309
16.
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer.
Sci Transl Med
; 12(537)2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32238575
17.
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma.
Nat Med
; 26(12): 1845-1851, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33046869
18.
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages.
Neuro Oncol
; 22(4): 539-549, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31755915
19.
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma.
Cancer Cell
; 37(5): 720-734.e13, 2020 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32359397
20.
Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b).
Mol Carcinog
; 48(6): 508-16, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18942117